- Cash
Volume Analysis
SPOT Pivot Levels
| Type | Classic | Fibonacci |
|---|---|---|
| R1 | 553.55 | 552.74 |
| R2 | 560.5 | 555.71 |
| R3 | 566.1 | 560.5 |
| PP | 547.95 | 547.95 |
| S1 | 553.55 | 552.74 |
| S2 | 535.4 | 540.19 |
| S3 | 528.45 | 535.4 |
Ratios
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| ROCE | - | 5.64 | - | 8.08 | - |
| ROE | - | 5.37 | - | 8.04 | - |
| EPS | -1.15 | 0.44 | 3.59 | 5.49 | 4.71 |
Peer Comparison
| Scrip Name | Price | Daily change | M Cap | PE Ratio | 1 Year Return |
|---|
Corporate Action
- Announcements
- Board Meetings
- Dividends
- Bonus
- Splits
- Rights
- AGM/EGM
- Credit Rating
About Orchid Pharma Ltd
Orchid Pharma Limited, is a vertically integrated pharmaceutical company with established research, manufacturing and marketing capabilities across multi-therapeutic domains. Orchid's world class manufacturing infrastructure include USFDA compliant API and Finished Dosage Form facilities at Chennai in India. The Company has dedicated state-of-art and GLP compliant R&D infrastructure for Process Re...
ISIN :INE191A01027
Registered Office
Orchid Towers Nungambakkam,313 Valluvar Kottam High Road
Contact number
+ 91-44-28211000/28230000
Registrars
-
Contact number
-
-
Management
R G Agarwal (Chairman)
FAQs
The share price of Orchid Pharma Ltd on the BSE is - as on -